Development of Ciprofloxacin HCl-Based Solid Lipid Nanoparticles Using Ouzo Effect: An Experimental Optimization and Comparative Study

Journal of Dispersion Science and Technology

Volumn 34, Issue 1, 2013, Pages 37-46

  Shah, Malay ^a   Agrawal, Yadvendra ^a  

^a GUJARAT FORENSIC SCIENCES UNIVERSITY   (India)

Author keywords

Central composite design; ciprofloxacin HCl; nanoemulsion; NLC; SLN

Indexed keywords

CENTRAL COMPOSITE DESIGNS; CIPROFLOXACIN; NANOEMULSION; NLC; SLN;

ANTIBIOTICS; ENCAPSULATION; OPTIMIZATION; ZETA POTENTIAL;

NANOPARTICLES;

EID: 84871480976     PISSN: 01932691     EISSN: 15322351     Source Type: Journal    
DOI: 10.1080/01932691.2011.646614     Document Type: Article

References (51)

1. Muller, R.H., Mader, K., and Gohla, S. (2000) Eur. J. Pharm. Biopharm., 50 (1): 161-177.
2. Schwarz, C., Mehnert, W., Lucks, J., and Müller, R. (1994) J. Control. Rel., 30 (1): 83-96.
3. Mehnert, W. and Mäder, K. (2001) Adv. Drug. Deliv. Rev., 47 (2-3): 165-196.
4. Domb, A.J. and Wiseman, D.M. (1997) Handbook of Biodegradable Polymers; Boca Raton, FL: CRC.
5. Bunjes, H., Drechsler, M., Koch, M.H.J., and Westesen, K. (2001) Pharm. Res., 18 (3): 287-293.
6. Müller, R.H., Maaben, S., Weyhers, H., and Mehnert, W. (1996) J. Drug Targeting, 4 (3): 161-170.
7. Storm, G., Belliot, S.O., Daemen, T., and Lasic, D.D. (1995) Adv. Drug. Deliv. Rev., 17 (1): 31-48.
8. Müller, R.H. and Olbrich, C. (1999) Pharm. Ind., 61: 564-569.
9. Shegokar, R., Singh, K., and Müller, R. (2011) Int. J. Pharm., 416 (2): 461-470.
10. Gokce, E.H., Ozyazici, M., and Souto, E.B. (2010) Therapeutic Delivery, 1 (1): 149-167.
11. Torchilin, V.P. (2006) Nanoparticulates as Drug Carriers; London: Imperial College Press.
12. Doroud, D., Vatanara, A., Zahedifard, F., Gholami, E., Vahabpour, R., and et al. (2010) J. Pharm. Pharma. Sci., 13 (3): 320-335.
13. Jenning, V., Schafer-Korting, M., and Gohla, S. (2000) J. Control. Release, 66 (2-3): 115-126.
14. Wissing, S., Kayser, O., and Muller, R. (2004) Adv. Drug. Deliv. Rev., 56 (9): 1257-1272.
15. Muller, R.H., Radtke, M., and Wissing, S. (2002) Int. J. Pharm., 242 (1-2): 121-128.
16. Müller, R.H., Radtke, M., and Wissing, S. (2002) Adv. Drug. Deliv. Rev., 54: S131-S55.
17. Schubert, M. and Muller-Goymann, C. (2005) Eur. J. Pharm. Biopharm., 61 (1-2): 77-86.
18. Han, F., Li, S., Yin, R., Liu, H., and Xu, L. (2008) Colloids Surf. A, 315 (1-3): 210-216.
19. Heurtault, B., Saulnier, P., Pech, B., Proust, J.E., and Benoit, J.P. (2003) Biomaterials, 24 (23): 4283-300.
20. Singh, S., Dobhal, A.K., Jain, A., Pandit, J.K., and Chakraborty, S. (2010) Chem. Pharm. Bull., 58 (5): 650-655.
21. Zhang, J., Fan, Y., and Smith, E. (2009) J. Pharm. Sci., 98 (5): 1813-1819.
22. Varshosaz, J., Ghaffari, S., Khoshayand, M.R., Atyabi, F., Azarmi, S., and Kobarfard, F. (2010) Journal of Liposome Research, 20 (2): 97-104.
23. Gonzalez-Mira, E., Egea, M., Souto, E., Calpena, A., and García, M. (2011) Nanotechnology, 22: 045101.
24. Ganachaud, F. and Katz, J.L. (2005) Chem. Phys. Chem., 6 (2): 209-216.
25. Higuchi, T. (1963) J. Pharm. Sci., 52 (12): 1145-1149.
26. Costa, P. and Sousa Lobo, J.M. (2001) Eur. J. Pharm. Sci., 13 (2): 123-33.
27. Gohel, M.C., Panchal, M.K., and Jogani, V.V. (2000) AAPS PharmSciTech, 1 (4): 43-48.
28. Hadjiioannou, T.P., Christian, G.D., Koupparis, M.A., and Macheras, P.E. (1993) Quantitative Calculations. In Pharmaceutical Practice and Research; NewYork: VCH.
29. Banker, G.S. and Rhodes, C.T. (2002) Modern Pharmaceutics; Boca Raton, FL: CRC.
30. Reza, M., Quadir, M.A., and Haider, S.S. (2002) Pak. J. Pharm. Sci., 15 (1): 63-70.
31. Trotta, M., Debernardi, F., and Caputo, O. (2003) Int. J. Pharm., 257 (1-2): 153-160.
32. Hoeller, S., Sperger, A., and Valenta, C. (2009) Int. J. Pharm., 370: 181-186.
33. Becher, P. (1983) Encyclopedia of Emulsion Technology: Basic Theory; Boca Raton, FL: CRC.
34. Trotta, M., Debernardi, F., and Caputo, O. (2003) Int. J. Pharm., 257 (1-2): 153-160.
35. Song, X., Zhao, Y., Wu, W., Bi, Y., Cai, Z., et al. (2008) Int. J. Pharm., 350 (1-2): 320-329.
36. Ledolter, J. (2011) Quality Technology & Quantitative Management, 8: 183-209.
37. Bhavsar, M.D., Tiwari, S.B., and Amiji, M.M. (2006) J. Control. Release, 110 (2): 422-30.
38. Vandervoort, J. and Ludwig, A. (2002) Int. J. Pharm., 238 (1-2): 77-92.
39. Leroux, J.C., Allemann, E., Doelker, E., and Gurny, R. (1995) Eur. J. Pharm. Biopharm., 41 (1): 14-18.
40. Shah, M. and Pathak, K. (2010) AAPS PharmSciTech, 11 (2): 489-496.
41. Komatsu, H., Kitajima, A., and Okada, S. (1995) Chem. Pharm. Bull., 43 (8): 1412-1415.
42. Shi, L., Li, Z., Yu, L., Jia, H., and Zheng, L. (2011) J. Dispersion Sci. Technol., 32: 254-259.
43. Yang, Y.Y., Chung, T.S., Bai, X.L., and Chan, W.K. (2000) Chem. Eng. Sci., 55 (12): 2223-2236.
44. Hao, J., Fang, X., Zhou, Y., Wang, J., Guo, F., et al. (2011) International Journal of Nanomedicine, 6: 683-692.
45. Rahman, Z., Zidan, A.S., and Khan, M.A. (2010) Eur. J. Pharm. Biopharm., 76 (1): 127-137.
46. Anantachaisilp, S., Smith, S.M., Treetong, A., Pratontep, S., Puttipipatkhachorn, S., and Ruktanonchai, U.R. (2010) Nanotechnology, 21: 125102.
47. Doktorovova, S. and Souto, E.B. (2009) Expert Opinion in Drug Delivery, 6: 165-176.
48. Huang, Z., Hua, S., Yang, Y., and Fang, J. (2008) Acta Pharm. Sin., 29 (9): 1094-1102.
49. Wang, J.J., Liu, K.S., Sung, K., Tsai, C.Y., and Fang, J.Y. (2009) Eur. J. Pharm. Sci., 38 (2): 138-146.
50. Hou, D.Z., Xie, C.S., Huang, K.J., and Zhu, C.H. (2003) Biomaterials, 24 (10): 1781-1785.
51. Hu, J., Johnston, K.P., and Williams III, R.O. (2004) Drug Dev. Indust. Phar., 30 (3): 233-245.